BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26166433)

  • 21. Rab35 is required for Wnt5a/Dvl2-induced Rac1 activation and cell migration in MCF-7 breast cancer cells.
    Zhu Y; Shen T; Liu J; Zheng J; Zhang Y; Xu R; Sun C; Du J; Chen Y; Gu L
    Cell Signal; 2013 May; 25(5):1075-85. PubMed ID: 23353182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.
    Dey N; Crosswell HE; De P; Parsons R; Peng Q; Su JD; Durden DL
    Cancer Res; 2008 Mar; 68(6):1862-71. PubMed ID: 18339867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CDX2 inhibits invasion and migration of gastric cancer cells by phosphatase and tensin homologue deleted from chromosome 10/Akt signaling pathway.
    Liu YQ; Bai ZG; Ma XM; Zhang ZT
    Chin Med J (Engl); 2015 Apr; 128(8):1065-71. PubMed ID: 25881601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tensins are versatile regulators of Rho GTPase signalling and cell adhesion.
    Blangy A
    Biol Cell; 2017 Mar; 109(3):115-126. PubMed ID: 27748980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S1P(2) receptors mediate inhibition of glioma cell migration through Rho signaling pathways independent of PTEN.
    Malchinkhuu E; Sato K; Maehama T; Mogi C; Tomura H; Ishiuchi S; Yoshimoto Y; Kurose H; Okajima F
    Biochem Biophys Res Commun; 2008 Feb; 366(4):963-8. PubMed ID: 18088600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Filamin A regulates monocyte migration through Rho small GTPases during osteoclastogenesis.
    Leung R; Wang Y; Cuddy K; Sun C; Magalhaes J; Grynpas M; Glogauer M
    J Bone Miner Res; 2010 May; 25(5):1077-91. PubMed ID: 19929439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function.
    Chan LK; Ko FC; Ng IO; Yam JW
    PLoS One; 2009; 4(5):e5572. PubMed ID: 19440389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MIF inhibits monocytic movement through a non-canonical receptor and disruption of temporal Rho GTPase activities in U-937 cells.
    DiCosmo-Ponticello CJ; Hoover D; Coffman FD; Cohen S; Cohen MC
    Cytokine; 2014 Sep; 69(1):47-55. PubMed ID: 25022961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.
    Hjelmeland AB; Hjelmeland MD; Shi Q; Hart JL; Bigner DD; Wang XF; Kontos CD; Rich JN
    Cancer Res; 2005 Dec; 65(24):11276-81. PubMed ID: 16357132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermal growth factor stimulates human trophoblast cell migration through Rho A and Rho C activation.
    Han J; Li L; Hu J; Yu L; Zheng Y; Guo J; Zheng X; Yi P; Zhou Y
    Endocrinology; 2010 Apr; 151(4):1732-42. PubMed ID: 20150581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DEF6, a novel PH-DH-like domain protein, is an upstream activator of the Rho GTPases Rac1, Cdc42, and RhoA.
    Mavrakis KJ; McKinlay KJ; Jones P; Sablitzky F
    Exp Cell Res; 2004 Apr; 294(2):335-44. PubMed ID: 15023524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
    Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
    Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases.
    Liliental J; Moon SY; Lesche R; Mamillapalli R; Li D; Zheng Y; Sun H; Wu H
    Curr Biol; 2000 Apr; 10(7):401-4. PubMed ID: 10753747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTEN inhibits PREX2-catalyzed activation of RAC1 to restrain tumor cell invasion.
    Mense SM; Barrows D; Hodakoski C; Steinbach N; Schoenfeld D; Su W; Hopkins BD; Su T; Fine B; Hibshoosh H; Parsons R
    Sci Signal; 2015 Mar; 8(370):ra32. PubMed ID: 25829446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK).
    Li G; Du X; Vass WC; Papageorge AG; Lowy DR; Qian X
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17129-34. PubMed ID: 21969587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
    Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
    J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
    Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
    Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Speed control for neuronal migration in the postnatal brain by Gmip-mediated local inactivation of RhoA.
    Ota H; Hikita T; Sawada M; Nishioka T; Matsumoto M; Komura M; Ohno A; Kamiya Y; Miyamoto T; Asai N; Enomoto A; Takahashi M; Kaibuchi K; Sobue K; Sawamoto K
    Nat Commun; 2014 Jul; 5():4532. PubMed ID: 25074242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rho A and Rac1: Antagonists moving forward.
    Salloum G; Jaafar L; El-Sibai M
    Tissue Cell; 2020 Aug; 65():101364. PubMed ID: 32746999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of nitric oxide interplay with Rho GTPase family members in modulation of actin membrane dynamics in pericytes and fibroblasts.
    Lee JS; Kang Decker N; Chatterjee S; Yao J; Friedman S; Shah V
    Am J Pathol; 2005 Jun; 166(6):1861-70. PubMed ID: 15920170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.